<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
IMVT
Immunovant
$
()


  • Immunovant management to meet with Piper Sandler

    4/24/2024 - 04:55am
  • Immunovant management to meet with Piper Sandler

    4/16/2024 - 15:04pm
  • Immunovant initiated with bullish view at Oppenheimer, here's why

    3/27/2024 - 16:07pm
  • JPMorgan reiterates Overweight ratings on Roivant, Immunovant

    3/26/2024 - 07:11am
  • Roche’s mixed myasthenia gravis data sending these stocks in opposite directions

    3/21/2024 - 10:54am
  • Tourmaline Bio might see weakness today after Roche MG data, says Truist

    3/21/2024 - 08:18am
  • Immunovant rallies after Chugai myasthenia gravis study failure

    3/21/2024 - 08:12am
  • Immunovant initiated with bullish view at Goldman Sachs, here's why

    3/13/2024 - 05:17am
  • Immunovant awarded U.S. patent for IMVT-1402

    3/12/2024 - 07:51am
  • Immunovant initiated with bullish view at JPMorgan, here's why

    2/20/2024 - 05:22am
  • Wolfe starts Immunovant at Outperform, says excited about catalyst path

    2/14/2024 - 19:17pm
  • Immunovant initiated with bullish view at Wolfe Research

    2/14/2024 - 16:16pm
  • Immunovant remains top pick at Citi after year-to-date selloff

    2/13/2024 - 07:17am
  • Immunovant options imply 3.5% move in share price post-earnings

    2/12/2024 - 15:04pm
  • Immunovant remains attractive despite stock underperformance, says Wells Fargo

    2/12/2024 - 12:47pm
dynamic_feed Breaking News